Panacos Pharmaceuticals, Inc.
PANC
$0.00
$0.000.00%
OTC PK
| 09/30/2008 | 06/30/2008 | ||||
|---|---|---|---|---|---|
| Revenue | 33.33% | -48.57% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 33.33% | -48.57% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | 33.33% | -48.57% | |||
| SG&A Expenses | -13.65% | -18.68% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -17.76% | 12.42% | |||
| Operating Income | 17.86% | -12.68% | |||
| Income Before Tax | 16.32% | -14.45% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 16.32% | -14.45% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 16.32% | -14.45% | |||
| EBIT | 17.86% | -12.68% | |||
| EBITDA | 18.05% | -12.80% | |||
| EPS Basic | 16.39% | -14.34% | |||
| Normalized Basic EPS | 16.37% | -14.29% | |||
| EPS Diluted | 16.39% | -14.34% | |||
| Normalized Diluted EPS | 16.37% | -14.29% | |||
| Average Basic Shares Outstanding | 0.11% | 0.07% | |||
| Average Diluted Shares Outstanding | 0.11% | 0.07% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||